R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma
-
- Thierry Lamy
- Hematology Department, Rennes University Hospital, INSERM Research Unit 1236, Rennes, France;
-
- Gandhi Damaj
- Hematology Department, Centre Hospitalier Universitaire (CHU) d’Amiens, INSERM U1245, Amiens, France;
-
- Pierre Soubeyran
- Bergonié Bordeaux Institute and Bordeaux University, Bordeaux, France;
-
- Emmanuel Gyan
- Hematology and Cell Therapy Department, Clinical Investigation Center (CIC) INSERM U1415, CHU de Tours, Université François Rabelais, Tours, France;
-
- Guillaume Cartron
- Hematology Department, CHU Montpellier, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5235, Montpellier, France;
-
- Krimo Bouabdallah
- Hematology and Cell Therapy Department, University Hospital of Bordeaux, Bordeaux, France;
-
- Rémy Gressin
- Onco Hematology Department, Hospital University Grenoble, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Site Santé, La Tronche, Grenoble, France;
-
- Jérôme Cornillon
- Hematology Department, Cancer Institute Lucien Neuwirth, Saint-Priest-en-Jarez, France;
-
- Anne Banos
- Hematology Department, Centre Hospitalier de la Côte Basque, Bayonne, France;
-
- Katell Le Du
- Hematology Department, Clinique Victor Hugo, Le Mans, France;
-
- Mohamed Benchalal
- Radiotherapy Department, Centre Eugène Marquis, Rennes, France;
-
- Marie-Pierre Moles
- Hematology Department, CHU d’Angers, Angers, France;
-
- Steven Le Gouill
- Hematology Department, CHU de Nantes, University of Nantes, INSERM team 10 UMR 892, Institut de Recherche en Santé de l’Université de Nantes, CIC Hospital Hôtel Dieu, Nantes, France;
-
- Joel Fleury
- Oncology Department, Médicale-Pôle Santé République, Clermont-Ferrand, France;
-
- Pascal Godmer
- Hematology Department, Centre Hospitalier de Vannes, Vannes, France;
-
- Hervé Maisonneuve
- Hematology Department, Centre Hospitalier Départemental de Vendée, La Roche-Sur-Yon, France;
-
- Eric Deconinck
- Hematology Department, Centre Hospitalier Regional Universitaire Besançon, INSERM UMR 1098, Université de Franche-Comté, Besançon, France;
-
- Roch Houot
- Hematology Department, Rennes University Hospital, INSERM UMR 1236, Rennes, France;
-
- Kamel Laribi
- Hematology Department, Centre Hospitalier du Mans, Le Mans, France;
-
- Jean Pierre Marolleau
- Hematology and Cell Therapy Department, CIC U1415, Department EA4666, CHU Amiens, Amiens, France;
-
- Olivier Tournilhac
- Hematology Department, CHU Clermont-Ferrand, Clermont-Ferrand, France;
-
- Bernard Branger
- Health Network of Pays de Loire, Nantes, France;
-
- Anne Devillers
- Nuclear Medicine Department, Centre Eugène Marquis, Rennes, France;
-
- Jean Philippe Vuillez
- Imaging Nuclear Medicine Department and Radiopharmaceutical and Bioclinical Department, CHU de Grenoble, INSERM U1039, Grenoble University, Grenoble, France;
-
- Thierry Fest
- INSERM UMR 1236, Rennes University, Etablissement Français du Sang and Laboratoire d’Hématologie, CHU de Rennes, Rennes, France;
-
- Philippe Colombat
- Hematology and Cell Therapy Department, CIC INSERM U1415, CHU de Tours, Université François Rabelais, Tours, France;
-
- Valérie Costes
- Pathology Department, CHU Montpellier, Montpellier, France;
-
- Vanessa Szablewski
- Pathology Department, CHU Montpellier, Montpellier, France;
-
- Marie C. Béné
- Hematology Biology, Nantes University Hospital, Nantes, France; and
-
- Vincent Delwail
- Hematology and Cell Therapy Department, CIC INSERM U1415, CHU de Poitiers, and CIC INSERM 1402, Université de Poitiers, Poitiers, France
書誌事項
- 公開日
- 2018-01-11
- DOI
-
- 10.1182/blood-2017-07-793984
- 公開者
- American Society of Hematology
この論文をさがす
説明
<jats:title>Key Points</jats:title> <jats:p>For early-stage DLBCL, R-CHOP alone is not inferior to R-CHOP followed by RT.</jats:p>
収録刊行物
-
- Blood
-
Blood 131 (2), 174-181, 2018-01-11
American Society of Hematology